Heron Therapeautics Inc (HRTX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -168.651 | -130.876 | -51.355 | -42.001 | -52.469 | -66.948 | -66.437 | -46.703 |
Return on Equity (%) | -357.516 | -359.438 | -71.351 | -52.907 | -70.988 | -140.535 | -405.769 | 1083.859 |
Return on Invested Capital (%) | -233.25 | -244.176 | -73.46 | -54.485 | -71.342 | -97.883 | -99.724 | -79.352 |
Operating Margin (%) | -13329.085 | -629.073 | -227.39 | -139.261 | -254.267 | -252.789 | -169.44 | -83.98 |
Net Profit Margin (%) | -13537.373 | -641.87 | -230.839 | -140.27 | -256.411 | -255.58 | -171.737 | -87.024 |
Book Value Per Share | -0.54 | 2.03 | 4.735 | 4.472 | 2.59 | 0.76 | 0.114 | -0.226 |
Earnings Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
Cash Per Share | 0.341 | 2.238 | 0.407 | 0.796 | 1.151 | 0.888 | 0.129 | 0.191 |
Working Capital Per Share | 0.595 | 1.933 | 4.544 | 4.234 | 2.318 | 1.798 | 1.033 | 0.727 |
Operating Profit Per Share | 0.032 | 0.429 | 0.658 | 0.957 | 0.606 | 0.425 | 0.443 | 0.432 |
EBIT Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
EBITDA Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
Free Cash Flow Per Share | -4.348 | -3.041 | -2.19 | -2.211 | -2.446 | -2.163 | -1.561 | -0.746 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 39.36M | 64.61M | 78.17M | 90.3M | 91.31M | 102.01M | 119.16M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | 119.16M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -110.647 | N/A | N/A | N/A | -9.115 | N/A |
Net Profit Margin (%) | N/A | N/A | -110.647 | N/A | N/A | N/A | -9.115 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 269.21M |
Price to Earnings Ratio | -2.35 |
Price to Sales Ratio | 2.04 |
Price to Cash Ratio | 9.04 |
Price to Book Ratio | -7.63 |
Dividend Yield | - |
Shares Outstanding | 151.67M |
Average Volume (1 week) | 1.38M |
Average Volume (1 Month) | 1.35M |
52 Week Change | 115.00% |
52 Week High | 3.93 |
52 Week Low | 0.50 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.